Company Filing History:
Years Active: 2021
Title: Juliantro Setiady: Innovator in Ovarian Cancer Diagnostics
Introduction
Juliantro Setiady is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of ovarian cancer detection. His innovative work focuses on the development of antibodies that can enhance therapeutic monitoring and improve patient outcomes.
Latest Patents
Juliantro Setiady holds a patent for a "Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody." This invention relates to antibodies that bind to the human folate receptor and includes diagnostic assays for therapies based on folate receptor 1. The methods he developed also provide ways to monitor therapy effectively.
Career Highlights
Setiady is currently associated with Immunogen, Inc., a company dedicated to developing innovative cancer therapies. His work at Immunogen has positioned him as a key player in the advancement of targeted cancer treatments.
Collaborations
He has collaborated with notable colleagues, including Olga Ab and Daniel J Tavares, to further enhance the research and development of cancer diagnostics and therapies.
Conclusion
Juliantro Setiady's contributions to ovarian cancer diagnostics exemplify the impact of innovative thinking in medicine. His work continues to pave the way for improved therapeutic strategies and patient care.